European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 have?
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 has 282 citations in the OpenAlex counts ScholarIQ stores.
When was European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 published?
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 has 2023 year in the ScholarIQ index.
What is the open-access status of European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023?
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 has bronze oa status in the ScholarIQ index.
What is the DOI of European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023?
The DOI for European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 is on the source record.
What is the PMID of European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023?
The PMID for European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 is on the source record.
What is the OpenAlex record for European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023?
The OpenAlex for European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 is on the source record.